More about
Datopotamab Deruxtecan
News
January 21, 2025
1 min read
Save
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.
News
October 05, 2024
1 min read
Save
Breast Cancer Awareness Month: New insights into lymphedema, genetic testing and AI
Breast Cancer Awareness Month is observed every October.
News
September 23, 2024
1 min read
Save
Datopotamab deruxtecan fails to extend OS vs. chemotherapy in advanced breast cancer
Datopotamab deruxtecan failed to extend OS vs. chemotherapy for adults with advanced breast cancer, according to the agent’s manufacturer.